Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DYRKs-IN-2 has antitumor activity. DYRKs-IN-2 is a potent DYRKs inhibitor with IC50s of 30.6 nM and 12.8 nM for DYRK1B and DYRK1A, respectively.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 8-10 weeks | $ 2,120.00 | |
50 mg | 8-10 weeks | $ 2,780.00 | |
100 mg | 8-10 weeks | $ 3,700.00 |
Description | DYRKs-IN-2 has antitumor activity. DYRKs-IN-2 is a potent DYRKs inhibitor with IC50s of 30.6 nM and 12.8 nM for DYRK1B and DYRK1A, respectively. |
Targets&IC50 | DYRK1B:30.6 nM , DYRK1A:12.8 nM |
In vitro | The EC50 of DyRKs-IN-2 is 22.8 nM for SW620 cell line. |
Molecular Weight | 632.16 |
Formula | C32H38ClN9O3 |
CAS No. | 1386980-04-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
DYRKs-IN-2 1386980-04-6 Cell Cycle/Checkpoint Tyrosine Kinase/Adaptors DYRK DYRKs IN 2 DYRKsIN2 inhibitor inhibit